What's happening
This bill adds a representative from the drug or medical device manufacturer industry to the New York State Board of Pharmacy.
Why it matters
Industry Insight on Policy. Adding a representative from the drug or medical device manufacturer industry to the Board of Pharmacy introduces direct input from the sector that develops and supplies many of the products pharmacists dispense, potentially influencing how regulatory decisions are made regarding these products.
Potential for Conflicts of Interest. Including an industry representative could raise concerns about conflicts of interest, as this member may have business priorities that do not always align with patient safety or public health objectives.
Broader Stakeholder Representation. This change means the Board of Pharmacy's decisions may reflect a wider array of perspectives, possibly leading to more comprehensive or practical rules and guidance, especially regarding new and emerging pharmaceutical and device technologies.
Impact on Pharmacy Practice and Regulation. The presence of an industry voice could affect policies related to drug/device approval, recalls, shortages, and educational requirements for pharmacists, shaping the landscape of pharmacy practice in New York.
Albany, before your first meeting.
Every bill that moved yesterday, summarized in a sentence and ranked by impact. The Albany Scorecard follows on Sundays.
Free. Unsubscribe in one click. Want alerts on specific bills? Create an account.
Who cares
Headline styles
Add Industry Rep to Pharmacy Board
Plain English, a few words. Used as the page title.
Sponsors
History
- Referred to higher education
- Referred to higher education
Full text
1 pageUnderlined is new[Struck] is removedOfficial text on nysenate.gov ↗
STATE OF NEW YORK
7212
2017-2018 Regular Sessions
IN ASSEMBLY
April 12, 2017
Introduced by M. of A. JONES -- read once and referred to the Committee on Higher Education
AN ACT to amend the education law, in relation to including a representative of the drug or medical device manufacturer industry on the state board of pharmacy
The People of the State of New York, represented in Senate and Assembly, do enact as follows:
Section 1. The opening paragraph of section 6804 of the education law, as added by chapter 987 of the laws of 1971, is amended to read as follows:
A state board of pharmacy shall be appointed by the regents on recommendation of the commissioner for the purpose of assisting the regents and the department on matters of professional licensing and professional conduct in accordance with section sixty-five hundred eight of this title. The board shall be composed of not less than [nine] ten members, nine of whom shall be pharmacists licensed in this state for at least five years, and one of whom shall be a representative of either drug or medical device manufacturers. An executive secretary to the board shall be appointed by the regents on recommendation of the commissioner and shall be a pharmacist licensed in this state for at least five years. The board shall have power:
§ 2. This act shall take effect on the sixtieth day after it shall have become a law.
EXPLANATION--Matter in italics (underscored) is new; matter in brackets
[ ] is old law to be omitted.
LBD09950-01-7
Reflowed for reading: line numbers and page breaks removed. Cite the official text.
Summaries, headlines and scores are AI-generated from the official bill text. How we score bills. Source: NYS Open Legislation.